Matches in SemOpenAlex for { <https://semopenalex.org/work/W56964327> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W56964327 endingPage "35" @default.
- W56964327 startingPage "429" @default.
- W56964327 abstract "Gabapentin (GBP) is a new antiepileptic agent with an original spectrum of activity. Its mechanism of action has not yet been fully elucidated but appears not to involve binding to GABA receptors despite being a structural analogue of GABA and is distinct from tricyclic antidepressants (TCAs). It has been shown to modulate high threshold calcium currents in brain neurons. As some other anticonvulsants, GBP has been recently proposed for the treatment of noncancer neuropathic pain like diabetic neuropathy and post herpetic neuralgia (double blind studies with placebo). We prospectively followed 20 cancer patients with advanced disease suffering from neuropathic pain. All were already treated for their pain syndrome. We started with 300 mg of GBP given orally in order to reach a dose of 900 mg on D3. All coanalgesics were stopped before entering the study. The only relevant side effect due to GBP was somnolence, otherwise time limited. GBP treatment was associated with a decrease of opioids doses in 9 patients and a decrease of VAS for pain intensity in all cases. Furthermore, the need of rescue doses decreased in all cases but 2. GBP appears to be one of the most effective drugs for the treatment of neuropathic pain. It is well tolerated and its effectiveness appears shortly after its administration. A synergistic action with opioids is suggested. Despite the small number of patients, our study suggests that GBP could be a treatment of neuropathic pain in cancer. Comparative trials should be performed with other neuropathic pain drugs including TCAs and antiepileptic drugs, especially carbamazepine." @default.
- W56964327 created "2016-06-24" @default.
- W56964327 creator A5003840472 @default.
- W56964327 creator A5053293171 @default.
- W56964327 creator A5089525740 @default.
- W56964327 date "2004-10-01" @default.
- W56964327 modified "2023-10-17" @default.
- W56964327 title "[Gabapentin (Neurontin) and cancer pain: a pilot study]." @default.
- W56964327 cites W1967785978 @default.
- W56964327 cites W1993697980 @default.
- W56964327 cites W2017865504 @default.
- W56964327 cites W2104660215 @default.
- W56964327 cites W2208092089 @default.
- W56964327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15584643" @default.
- W56964327 hasPublicationYear "2004" @default.
- W56964327 type Work @default.
- W56964327 sameAs 56964327 @default.
- W56964327 citedByCount "3" @default.
- W56964327 countsByYear W569643272014 @default.
- W56964327 crossrefType "journal-article" @default.
- W56964327 hasAuthorship W56964327A5003840472 @default.
- W56964327 hasAuthorship W56964327A5053293171 @default.
- W56964327 hasAuthorship W56964327A5089525740 @default.
- W56964327 hasConcept C142724271 @default.
- W56964327 hasConcept C197934379 @default.
- W56964327 hasConcept C204787440 @default.
- W56964327 hasConcept C27081682 @default.
- W56964327 hasConcept C2776468701 @default.
- W56964327 hasConcept C2776608144 @default.
- W56964327 hasConcept C2777107010 @default.
- W56964327 hasConcept C2779034229 @default.
- W56964327 hasConcept C2780016216 @default.
- W56964327 hasConcept C42219234 @default.
- W56964327 hasConcept C71924100 @default.
- W56964327 hasConcept C98274493 @default.
- W56964327 hasConceptScore W56964327C142724271 @default.
- W56964327 hasConceptScore W56964327C197934379 @default.
- W56964327 hasConceptScore W56964327C204787440 @default.
- W56964327 hasConceptScore W56964327C27081682 @default.
- W56964327 hasConceptScore W56964327C2776468701 @default.
- W56964327 hasConceptScore W56964327C2776608144 @default.
- W56964327 hasConceptScore W56964327C2777107010 @default.
- W56964327 hasConceptScore W56964327C2779034229 @default.
- W56964327 hasConceptScore W56964327C2780016216 @default.
- W56964327 hasConceptScore W56964327C42219234 @default.
- W56964327 hasConceptScore W56964327C71924100 @default.
- W56964327 hasConceptScore W56964327C98274493 @default.
- W56964327 hasIssue "5" @default.
- W56964327 hasLocation W569643271 @default.
- W56964327 hasOpenAccess W56964327 @default.
- W56964327 hasPrimaryLocation W569643271 @default.
- W56964327 hasRelatedWork W2141918005 @default.
- W56964327 hasVolume "25" @default.
- W56964327 isParatext "false" @default.
- W56964327 isRetracted "false" @default.
- W56964327 magId "56964327" @default.
- W56964327 workType "article" @default.